New boss brings diagnostic edge to PEB

New boss brings diagnostic edge to PEB
Peter Meintjes has experience in the global molecular diagnostics sectors relevant to Pacific Edge’s Cxbladder products. (Image: Supplied)
Dan Brunskill
Pacific Edge has appointed a molecular diagnostics expert to lead the cancer diagnostics company after the retirement of long-serving chief executive David Darling.The new CEO, Peter Meintjes, has a PhD in biological sciences from Auckland University and has been chief commercial officer of US-based organ transplant testing company Eurofins Transplant Genomics.Prior to that he served as chief executive of Hungary-based Omixon, another global molecular diagnostics company focused on organ and recipient compatibility testing.Pacific Edge said whi...

More Markets

NZD outlook: 2025 more about surviving
Markets

NZD outlook: 2025 more about surviving

The kiwi shed more than 11% in 2024, and we already see more downsides. 

Rate decision odds are tight, NZD set for a wild ride
Markets Best of BusinessDesk

Rate decision odds are tight, NZD set for a wild ride

It did turn out to be an understatement. 

Analysts expect RV companies to raise equity
Property

Analysts expect RV companies to raise equity

“We expect investor support for a capital raise," Jarden's Arie Dekker said.

Cross-border rules on aviation emissions give airlines easy ride
Markets

Cross-border rules on aviation emissions give airlines easy ride

Around 80% of Air NZ's emissions from jet fuel are from international flights.